Application of Cys C and UmAlbUCr Test in the Early Screening of Diabetic Nephropathy  

作　　者：QINJinyan 

机构地区：[1]Qianxinan Hospital of Traditional Chinese Medicine, Qianxinan Guizhou 562400, China

出　　处：《外文科技期刊数据库(文摘版)医药卫生》2022年第9期028-031,共4页

摘　　要：Objective: to explore the combination of blood Cys-C (Cys-C) and UmAlb / UCr (creatinine ratio in urinary microalbuminuria) for the early screening of diabetic kidney disease. Methods: 60 patients were selected and considered as clinical research subjects. Sixty patients admitted from March 2021 to March 2022 were selected as controls. The changes of plasma cystatin and urinary microalbuminuria creatinine were compared between the two groups by using the dynamic method of immune transmission ratio, scattering ratio method and picric acid. Results: 60 patients with diabetic nephropathy were selected and considered as clinical research subjects. Sixty patients admitted from March 2021 to March 2022 were selected as controls. The changes of plasma cystatin and urinary microalbuminuria creatinine were compared between the two groups by using the dynamic method of immune transmission ratio, scattering ratio method and picric acid. Conclusion: the relationship between the CH index in blood and the creatinine ratio in urine is explored, and the detection accuracy is significantly higher than that of the two indicators alone, which can effectively improve the accuracy and sensitivity of the early detection of diabetic nephropathy and improve the early diagnosis rate. It can be used as an excellent detection method. It has high clinical value and deserves further promotion and use.

关 键 词：serum cystatin urinary microalbumin urinary creatinine early diabetic nephropathy early screening 

分 类 号：R587.2[医药卫生—内分泌]